8-K filing — Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Filed: 2026-09-16 AccNo: 0001493152-26-042791 Size: 209 KB Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Shuttle Pharmaceuticals Q2 EPS $(3.10) Up From $(32.90) YoY
Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(3.10) per share. This is a 90.58 percent increase over losses of $(32.90) per share from the same period last year.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K/A filing — Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Filed: 2026-08-17 AccNo: 0001493152-26-038786 Size: 213 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits
Why Vision Marine Technologies Shares Are Trading Higher By Over 60%; Here Are 20 Stocks Moving Premarket
Vision Marine Technologies Inc (NASDAQ: VMAR) gained 60.3% to $2.26 in pre-market trading after reporting third-quarter financial results with 27% jump in revenue. Other gainers and losers also listed.